Evidence map›Paper›PMID 39459025›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease.

Daniela Di Grazia, Cristina Mirabella, Francesco Chiara, Maura Caudana, Francesco Maximillian Anthony Shelton Agar, Marina Zanatta, Sarah Allegra, Jenni Bertello, Vincenzo Voi, Giovanni Battista Ferrero and 2 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Role ofLife (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniela Di GraziaLaboratory of Clinical Pharmacology "Franco Ghezzo", Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.ORCID 0009-0007-1869-6762
Cristina MirabellaLaboratory of Clinical Pharmacology "Franco Ghezzo", Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Francesco ChiaraLaboratory of Clinical Pharmacology "Franco Ghezzo", Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Maura CaudanaLaboratory of Clinical Pharmacology "Franco Ghezzo", Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Francesco Maximillian Anthony Shelton AgarLaboratory of Clinical Pharmacology "Franco Ghezzo", Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Marina ZanattaDepartment of Economics and Statistics "Cognetti de Martiis", University of Turin, 10124 Turin, Italy.
Sarah AllegraLaboratory of Clinical Pharmacology "Franco Ghezzo", Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.ORCID 0000-0003-4933-0011
Jenni BertelloMicrocythemia and Rare Haematological Diseases Center, Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Vincenzo VoiMicrocythemia and Rare Haematological Diseases Center, Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.ORCID 0000-0001-7249-2735
Giovanni Battista FerreroMicrocythemia and Rare Haematological Diseases Center, Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Giuliana AbbadessaLaboratory of Clinical Pharmacology "Franco Ghezzo", Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.ORCID 0000-0003-2727-2519
Silvia De FranciaLaboratory of Clinical Pharmacology "Franco Ghezzo", Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.ORCID 0000-0002-9841-7802

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

area under the curvehigh-pressure liquid chromatographymaximum tolerated dosesextherapeutic drug monitoringvariability

Identifiers

PMID39459025
PMCPMC11510670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.